All news articles for August 2015

Novo opts to build US API capacity for semaglutide rather than outsource

To supply the Dane: Novo expects First API batch in 2020


Novo Nordisk has confirmed it will build an API plant in the US, telling this publication a desire to have manufacturing capacity in the key market for its oral diabetes candidate, semaglutide, drove the decision.

Online customers are prey to fake pharmacies, says MHRA

MHRA uncovers $1m illegal ED drug haul

By Fiona BARRY

A UK man has been sentenced to 16 months in prison for smuggling illegal erectile dysfunction drugs following an MHRA investigation.

MHRA says incorrect fee payments are holding up applications

MHRA launches fees calculator

By Fiona BARRY

The UK regulator is launching a calculator to help pharma companies calculate the fees for drug applications.